Page last updated: 2024-11-02

phenylbutazone and Liver Steatosis

phenylbutazone has been researched along with Liver Steatosis in 2 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research Excerpts

ExcerptRelevanceReference
" So based on the characteristics that phenylbutazone has a good combination with HSA, we selected a proper linker to link with PYY24-36 -Leu31 to create long-acting and highly biologically active PYY24-36 -Leu31 conjugates, and successfully find a novel, long-acting PYY24-36 -Leu31 conjugate 8 that, when dosed every other day in diet induce obese (DIO) mice for 2 weeks, results in a significant reduction in food intake and body weight and improvement in blood parameter and hepatic steatosis."1.43Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier. ( Huang, W; Li, X; Qian, H; Qiu, Q; Sun, J; Zhou, J; Zhu, X, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, J1
Li, X1
Zhu, X1
Sun, J1
Qiu, Q1
Huang, W1
Qian, H1
Altmann, HW1

Other Studies

2 other studies available for phenylbutazone and Liver Steatosis

ArticleYear
Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier.
    Chemical biology & drug design, 2016, Volume: 87, Issue:6

    Topics: Animals; Drug Carriers; Fatty Liver; Humans; Male; Mice; Mice, Inbred ICR; Mice, Obese; Phenylbutazo

2016
Morphological changes in the liver due to phenazone and its derivatives.
    Agents and actions. Supplements, 1986, Volume: 19

    Topics: Antipyrine; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Fatty Liver; Granulom

1986